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Tumour-elicited neutrophils engage mitochondrial
metabolism to circumvent nutrient limitations and
maintain immune suppression
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Neutrophils are a vital component of immune protection, yet in cancer they may promote
tumour progression, partly by generating reactive oxygen species (ROS) that disrupts lym-
phocyte functions. Metabolically, neutrophils are often discounted as purely glycolytic. Here
we show that immature, c-Kit+ neutrophils subsets can engage in oxidative mitochondrial
metabolism. With limited glucose supply, oxidative neutrophils use mitochondrial fatty acid
oxidation to support NADPH oxidase-dependent ROS production. In 4T1 tumour-bearing
mice, mitochondrial ﬁtness is enhanced in splenic neutrophils and is driven by c-Kit signalling.
Concordantly, tumour-elicited oxidative neutrophils are able to maintain ROS production and
T cell suppression when glucose utilisation is restricted. Consistent with these ﬁndings,
peripheral blood neutrophils from patients with cancer also display increased immaturity,
mitochondrial content and oxidative phosphorylation. Together, our data suggest that the
glucose-restricted tumour microenvironment induces metabolically adapted, oxidative neu-
trophils to maintain local immune suppression.
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The importance of neutrophils in the establishment andprogression of tumours has been widely reported, withmultiple tumour modulatory functions identiﬁed. Neu-
trophils promote tumour progression by increasing invasion and
metastasis through releasing proteases1,2, increasing
angiogenesis3,4 and directly promoting tumour growth5–7.
Additionally, neutrophils have been shown to limit anti-tumour
immune responses by suppressing T cell8–10 and NK-cell11
activity, through various factors such as arginase12 and reactive
free radicals; namely reactive nitrogen13 and oxygen14 species.
Neutrophils have also been included as part of the myeloid-
derived suppressor cells (MDSC), a mixed population of myeloid
cells, including immature neutrophils and monocytes, deﬁned by
their immune suppressive and tumour promoting capacity9,15–17.
However, consensus on the separation between the granulocytic
(g)MDSC subset and neutrophils is controversial and this
nomenclature implies that neutrophils in the cancer setting are
purely immunosuppressive and pro-tumour in nature, despite
described anti-tumour functions18. This confusion can be
attributed to the unknown predictive factors which lead to this
neutrophil functional dichotomy.
In recent years, advances in our understanding of metabolism
and its effects on cell function has opened new avenues in leu-
kocyte biology, impacting both cancer biology and immunology.
Tumours and immune cells engage in bi-directional manipula-
tion of their respective metabolism, thereby altering cell function
to facilitate tumour progression19,20. This can occur by direct
reprogramming of target cell metabolism21 or by competition for
fuels in the tumour microenvironment (TME) leading to star-
vation or adaptions to metabolic stress22. However, despite our
recent advances in the understanding of leukocyte metabolism
and the known importance of neutrophils in tumour progres-
sion, neutrophil metabolic status and the impact it plays on
effector functions remain poorly studied. Traditionally, neu-
trophils have been thought to be a highly glycolytic population,
dependent on glucose, with little or no mitochondrial function
except to drive apoptosis23. Recently however, neutrophil
metabolism has gained interest as the importance of mitochon-
dria in effector functions such as chemotaxis24 and the genera-
tion of neutrophil extracellular traps (NETs) have come to
light25. Recently, MDSC function was shown to have speciﬁc
metabolic underpinnings, with tumour-associated MDSC exhi-
biting increased fatty acid oxidation and mitochondrial function
that correlated with immunosuppressive capacity26. These stu-
dies however, did not deﬁne the MDSC sub-populations, dissect
how mitochondrial function was enhanced or delineate how it
contributed to the suppressive action of these cells. Therefore, it
is possible, that a role for neutrophil metabolic programming has
overlooked due to their inclusion within the broad category of
MDSC.
In this study, we characterise neutrophil mitochondrial func-
tion under healthy physiological conditions and in the cancer
setting. We demonstrate that tumour elicited c-Kit signalling in
neutrophils drives an oxidative phenotype with enhanced mito-
chondrial function. Surprisingly, we ﬁnd that oxidative neu-
trophils utilize their mitochondria to maintain intracellular
NADPH levels and support reactive oxygen species (ROS) pro-
duction through NADPH oxidase when glucose utilisation is
limited. Our data suggest that oxidative neutrophils beneﬁt
tumour growth as, unlike glycolytic-neutrophils from a healthy
host, they can maintain ROS-mediated suppression of T cells
even in the nutrient limited TME. These data shed new light on
the role of mitochondria in phagocyte function and suggest that
neutrophil mitochondrial metabolism could prove an effective
target for cancer therapy.
Results
c-Kit is a marker of immature oxidative neutrophils. Very little
is known about neutrophil mitochondrial activity and how it may
relate to their developmental state or function in different tissue
settings. Therefore, initial experiments characterised neutrophil
mitochondrial function in distinct tissue locations. Bone marrow-
derived neutrophils possessed signiﬁcantly greater basal mito-
chondrial oxygen consumption rate (OCR) when compared to
neutrophils from peripheral blood or spleen (Fig. 1a). As bone
marrow is the primary site of haematopoiesis, we hypothesised
that elevated mitochondrial capacity might be related to an
immature phenotype. Expression of the chemokine receptor
CXCR2, and the stem cell factor (SCF) receptor c-Kit, markers of
neutrophil maturity and immaturity respectively27, identiﬁed two
distinct populations of Ly-6G+ cells (Fig. 1b, Supplemental
Fig. 1a). Nuclear morphology conﬁrmed that c-Kit+/CXCR2−
neutrophils were a more immature subset compared to c-Kit
−/CXCR2+ cells, with a higher percentage of unsegmented nuclei
with an immature chromatin pattern (Fig. 1c and Supplemental
Fig. 1b). c-Kit+ neutrophils did not express monocyte markers
Ly-6C or CD115 (MCSFR) (Supplemental Fig. 1c), but instead
expressed markers consistent with mature c-Kit− neutrophils
such as CD62L and CD11b (Supplemental Fig. 1d). Accordingly,
c-Kit expression in neutrophils was largely conﬁned to the bone
marrow with low percentages found in the spleen and circulation
(Fig. 1d). Following isolation (Supplemental Fig. 1e), seahorse
extracellular ﬂux analysis demonstrated that c-Kit+ neutrophils
possess a signiﬁcantly higher reserve and maximal mitochondrial
OCR than c-Kit− neutrophils (Fig. 1e). Moreover, analysis of
extra-cellular acidiﬁcation rates (ECAR), a measurement related
to the production of lactic acid and therefore the glycolytic rate,
revealed that OCR/ECAR ratios of c-Kit+ neutrophils were sub-
stantially higher than c-Kit− cells (Fig. 1f), suggesting a greater
propensity for mitochondrial function as opposed to glycolysis to
meet energy demands. Further investigation identiﬁed a bone
marrow resident c-Kit+ ly6Gint population (Supplemental
Fig. 2a) with a greater reserve and maximal mitochondrial OCR
(Supplemental Fig. 2b,c). This population displayed a more
myelocyte-like nuclear morphology9 (Supplemental Fig. 2d), a
reduced expression of Ly-6G and increased expression of Ly-6C
and MCSF-R (CD115) (Supplemental Fig. 2e,f), suggesting that
this population represents granulocyte/monocyte myelocyte pre-
cursor and that loss of mitochondrial metabolism may be indi-
cative of neutrophil development.
Consistent with a greater capacity for oxidative phosphoryla-
tion (OXPHOS), tetramethylrhodamine, ethyl ester (TMRE)
staining determined that c-Kit+ neutrophils possess greater
mitochondrial membrane potential when compared to c-Kit−
neutrophils (Fig. 1g). Additionally, c-Kit+ neutrophil mitochon-
dria possess greater quantities of mitochondrial complexes I, II,
III and V (Fig. 1h), mitochondrial enzymes pyruvate dehydro-
genase (PDH), α-ketoglutarate dehydrogenase (αKGDH) and
aconitase 2 (ACO2) (Supplemental Fig. 2g). Furthermore, these
cells contained increased mitochondrial DNA (Supplemental
Fig. 2h) consistent with increased mitochondrial mass. In-gel
activity assays also showed greater activity for mitochondrial
complex I, II and IV (Supplemental Fig. 2i).
c-Kit+ neutrophils displayed a distinct metabolite proﬁle
compared to c-Kit− neutrophils (Supplemental Fig. 2j). Promi-
nently, arginine metabolism, which can support tissue repair and
proliferation28, was identiﬁed by ingenuity pathway analysis
(IPA) of metabolite content, with higher ornithine and subse-
quently spermidine and proline in c-Kit+ neutrophils. In
addition, the levels of nine amino acids were increased in
c-Kit+ neutrophils, which may indicate higher levels of
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anaplerotic metabolism29. Collectively these data suggest that c-
Kit expression is a marker of an immature neutrophil subset,
largely restricted to the bone marrow with a drastically different
metabolic programming compared to their more mature c-Kit−
counterparts, as evidenced by their metabolic proﬁle and higher
mitochondrial capacity.
Neutrophil mitochondria facilitate free radical production.
Neutrophils engage in the generation of ROS and other free
radicals in a process termed respiratory burst. This process was
originally characterised as an increase in oxygen consumption as
molecular oxygen is consumed to form free radicals such as
superoxide (O2−) and hydrogen peroxide (H2O2). Therefore, we
dissected the metabolic underpinning of respiratory burst by
monitoring the substantial increase in OCR in response to the
PKC agonist phorbol 12-myristate 13-acetate (PMA) in bone
marrow-derived neutrophils. Inhibition of mitochondrial func-
tion with rotenone and antimycin A (complex I and III inhibitors,
respectively) during respiratory burst did not affect peak OCR but
rather lead to reductions during the later phases of the response
(Fig. 2a, Supplemental Fig. 3a). In contrast, the contribution of
glucose utilisation was assessed using the competitive inhibitor 2-
deoxy-D-glucose (2DG) to investigate glucose-independent
pathways. 2DG treatment altered both the peak and the kinetics
of respiratory burst, reducing OCR in the initial earlier phase
while the later phase remained unaffected (Fig. 2a, Supplemental
Fig. 3a).
Unexpectedly for a reportedly glucose-dependent cell, there
remained substantial OCR following the disruption of glucose
metabolism. To uncover the metabolic components of respiratory
burst during 2DG restriction of glucose metabolism, we employed
mitochondrial inhibition following PMA stimulation. Mitochon-
drial inhibition led to dramatic reductions in OCR during 2DG
treatment, demonstrating mitochondrial involvement during
glucose-independent respiratory burst (Fig. 2b, Supplemental
Fig. 3b). Conversely, inhibition of glucose utilisation after
mitochondrial complex inhibition also signiﬁcantly limited
respiratory burst (Fig. 2b, Supplemental Fig. 3b). These data
strongly suggested that bone marrow neutrophils maintain
respiratory burst via both glucose metabolism and mitochondrial
function. Although OCR is indicative of respiratory burst, it is not
a direct measurement of ROS production. Therefore, H2O2
production was directly measured in PMA activated neutrophils
following disruption of glucose utilisation or mitochondrial
function (Fig. 2c). Consistent with our OCR data, blockade of
mitochondrial function alone during respiratory burst did not
affect peak ROS production but inhibited late H2O2 production
(Fig. 2c). In contrast, blockade of glucose utilisation by 2DG
revealed a distinct ROS production proﬁle, reduced in amplitude
and prolonged in length when compared to mitochondrial
inhibition. Treatment with acetylcarnitine transport inhibitor
etomoxir, showed that fatty acid utilisation is required to
maintain PMA-induced OCR (Fig. 2d, Supplemental Fig. 3c)
following treatment with 2DG and both fatty acid metabolism
and mitochondrial function was required H2O2 production under
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Fig. 1 c-Kit is a marker of immature oxidative neutrophils. a Determination of C57BL/6J neutrophil basal mitochondrial oxygen consumption rates (OCR,
left) following inhibition of electron transport chain components (Rotenone 100 nM and antimycin A 1 µM). Quantiﬁcation of basal mitochondrial OCR
from multiple independent experiments (right). Data were analysed by one-way ANOVA with Tukey’s post-tests indicated. Bone marrow and spleen n= 4,
blood n= 3. b Representative ﬂow cytometry plot of Ly6G+ neutrophils displaying c-Kit+ CXCR2− and c-Kit− CXCR2+ populations from naive C57BL/6
bone marrow. Histograms represent c-Kit expression of populations. c Representative nuclear morphology of bone marrow neutrophils following cytospin
and Romanowsky staining. Scale bar represents 10 μm. d Percentage of neutrophils expressing c-Kit isolated from different tissues (BM—bone marrow).
Data (n= 10 per group) represents two independent experiments, data were analysed by one way ANOVA, Tukey’s post-tests are indicated on the graph.
e Representative mitochondrial stress test (left) in bone marrow neutrophils (oligomycin 1.26 µM, Carbonyl cyanide-4-(triﬂuoromethoxy) phenylhydrazone
(FCCP) 660 nM, Rotenone 100 nM and antimycin A 1 µM). Mitochondrial reserve and maximal OCR are quantiﬁed from multiple independent experiments
(right). Data (n= 3 per group) were analysed by two-way ANOVA with Tukey’s post-tests indicated. f OCR:extracellular acidiﬁcation rate (ECAR) ratios of
neutrophil subsets. Data (c-Kit+ n= 3, c-Kit− n= 9) were analysed by Student's t-test and is representative of three independent experiments. g Median
ﬂuorescent intensity of tetramethylrhodamine ethyl ester (TMRE) staining, which indicates active mitochondrial content in neutrophil subsets. Data were
analysed by Student's t-test, data (n= 4 per group) represents two independent experiments. h Western blotting for mitochondrial complexes I
(NDUFB8), II (SDHB), III (UQCRC2) and V (ATP5A) in neutrophil subsets. CYT cytosolic, MIT mitochondrial. Data is representative of two repeats (n= 3).
p Values *<0.05, **<0.01, ***<0.001. All error bars represent the mean ± SEM
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these conditions (Fig. 2e). Together these data show that optimal
ROS production requires two distinct metabolic pathways, with
glucose metabolism being required for early phase high-intensity
ROS production and mitochondrial function facilitating late
phase prolonged H2O2 production.
Recent studies have demonstrated that respiratory burst in
macrophages is dependent on mitochondrial function and
involves increased dependency on mitochondrial complex II
and the decoupling of mitochondria from OXPHOS by complex
V30,31. To assess the involvement of individual mitochondrial
complexes during glucose-independent respiratory burst in
neutrophil, we used speciﬁc inhibitors to components of the
mitochondrial electron transport chain (ETC). Inclusion of
inhibitors to mitochondrial complex I, II or III all signiﬁcantly
reduced glucose-independent respiratory burst (Fig. 2f, Supple-
mental Fig. 3d). Contrary to previous reports in macrophages,
complex V (ATP synthase) inhibition also ablated glucose-
independent respiratory burst in neutrophils (Fig. 2g, Supple-
mental Fig. 3e). Inhibition of complex V not only inhibits ATP
production, but also suppresses electron ﬂow through the ETC by
blocking the recycling of hydrogen ions into the mitochondrial
matrix. To differentiate between these possibilities, we used the
mitochondrial uncoupler carbonyl cyanide-4(triﬂuoromethoxy)
phenylhydrazone (FCCP) alongside oligomycin to allow hydro-
gen recycling and electron transport to the matrix in the absence
of ATP synthesis. These data demonstrated that in neutrophils
ATP production by complex V and not simply proton recycling
was required for respiratory burst (Fig. 2g, Supplemental Fig. 3e).
Direct measurement of ATP showed that the majority of ATP
was maintained by glucose metabolism, however in the absence of
glucose utilisation, mitochondrial function was required to
maintain ATP levels (Fig. 2h). Conversely, disruption of fatty
acid metabolism which suppressed respiratory burst (Fig. 2d, e)
did not signiﬁcantly reduce ATP levels, suggesting that
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Fig. 2 Neutrophil mitochondria facilitate free radical production. a C57Bl/6J bone marrow neutrophil respiratory burst was measured by oxygen
consumption rate (OCR) in response to phorbol 12-myristate 13-acetate (PMA) at the arrow following the addition of indicated compounds at the dotted
line. b Following stimulation as described in panel (a), neutrophils received a second stimulation of indicated compounds at the second line. Control from
panel (a). c H2O2 production from bone marrow neutrophils in response to PMA 20min after the addition of the indicated individual compounds. d OCR in
response to the indicated compounds at the second line following the addition of PMA (arrow) and 2DG (ﬁrst line). e H2O2 production in response to PMA
20min after addition of 2DG alone or in combination with the indicated compounds. f OCR values in response to Inhibitors to electron transport chain
complexes (CI-III) added at the second line following stimulation with PMA (arrow) and 2DG (ﬁrst line). g OCR in response to the complex V inhibitor
Oligomycin and Carbonyl cyanide-4-(triﬂuoromethoxy)phenylhydrazone (FCCP) were added at the second line, following stimulation with PMA (arrow)
and 2DG (ﬁrst line). h ATP content of PMA-stimulated bone marrow neutrophils following inhibition with indicated compounds in the presence or absence
of 2DG. Data (n= 5 per group) were analysed by two-way ANOVA with Tukey’s multiple comparisons indicated. i OCR in p47−/− neutrophils in response
to PMA (arrow). j Relative total oxygen consumption in response to PMA during NADPH oxidase inhibition by VAS-2870 in the presence or absence of
2DG. Data were analysed by Student's t-test. Control n= 3 pooled from three independent experiments, 2DG n= 4 pooled from two independent
experiments. k Relative NADPH levels in PMA-stimulated neutrophils in the presence or absence of 2DG following treatment with indicated compounds.
Data (n= 5) representative of two independent experiments and were analysed by two-way ANOVA with Tukey’s multiple comparisons indicated. l
Schematic displaying our metabolic model of ROS support, with indicated inhibitors. Concentrations were: Rotenone (Rot, 100 nM), Atpenin (1 µM),
Antimycin A (AA, 1 µM), 2-DG (100mM), PMA (1 µg/ml), FCCP (660 nM), etomoxir (100 µM), Oligomycin (1.26 µM), and VAS-2870 (10 μM). p Values
*<0.05, ***<0.001. All error bars denote the mean ± SEM
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maintenance of ATP production alone may not fully account for
the mechanism by which neutrophils engage in respiratory burst
in the absence of glucose metabolism.
Respiratory burst in neutrophils is heavily dependent on the
NADPH-oxidase (NOX) complex which utilises NADPH to
generate superoxide, yielding NADP+. However previous studies
have demonstrated that mitochondria can contribute to respira-
tory burst in macrophages and neutrophils by acting as a direct
generator of ROS30,32. It is therefore possible that in the absence
of glucose utilisation, bone marrow-derived oxidative-neutrophils
could switch their source of ROS generation from NOX to
mitochondria. PMA stimulated neutrophils deﬁcient in the
NOX2 subunit p47 (p47−/−) were unable to undergo a signiﬁcant
respiratory burst (Fig. 2i). However, ROS production was
detected by the ﬂuorescent probe 2′,7′-dichloroﬂuorescin diace-
tate (DCFDA) in p47−/− neutrophils following PMA stimulation,
albeit to a lesser extent than wild type neutrophils and was not
detected by aminophenyl ﬂuorescein (APF) (Supplemental
Fig. 3f). This activity coincided with an increase in rotenone
and antimycin A sensitive OCR following exposure to PMA in
p47−/− neutrophils, suggesting that that the ROS detected by
DCFDA was due to an increase in mitochondrial activity
(Supplemental Fig. 3g). This activity was further increased
following 2DG treatment, suggesting that increased mitochon-
drial activity may be an adaption to maintain responses when
glucose metabolism is limited (Supplemental Fig. 3g).
Furthermore, using the NOX inhibitor VAS2870, PMA-
induced respiratory burst was found to be equally dependent
on NOX activity in the presence and absence of intact glucose
metabolism (Fig. 2j). These data suggest that in the absence of
glucose, mitochondria are not functioning as the site of ROS
production, as has been reported in macrophages30, but may
support NOX activity through NADPH production. To investi-
gate this possibility, we measured NADPH levels during PMA
stimulation (Fig. 2k). These data demonstrated that inhibition of
mitochondrial function or fatty acid usage alone had no effect on
NADPH maintenance. Remarkably however, when glucose usage
is limited the inhibition of either mitochondrial function or fatty
acid metabolism signiﬁcantly reduced NADPH levels (Fig. 2k).
Taken together, these data suggest that neutrophils are able to
utilize two metabolic pathways to maintain respiratory burst
activity. Initially ROS production is dependent on glucose
utilisation to maintain cellular ATP and NADPH levels. However,
when glucose metabolism is limiting, neutrophils become
dependent on mitochondrial metabolism to support cellular
ATP and in particular fatty acid metabolism to support NOX
activity, through the maintenance of NADPH levels (Fig. 2l).
Mitochondrial capacity aids ROS production in low glycolysis.
Having established that mitochondrial function can support
respiratory burst when glucose usage has been inhibited, we
hypothesized that neutrophil with greater mitochondrial function
may better maintain ROS production in the absence of glucose.
To address this possibility, we compared neutrophils from the
bone marrow and spleen, two populations with differing mito-
chondrial capacity (Fig. 1a). Splenic neutrophils were unable to
maintain respiratory burst at lower concentrations of glucose or
treatment with 2DG (Fig. 3a). In contrast, bone marrow-derived
neutrophils maintained respiratory burst in low glucose or during
2DG treatment. Moreover, c-Kit+ neutrophils were better able to
maintain respiratory burst in limiting glucose when compared to
c-Kit− neutrophils (Fig. 3b). c-Kit+ neutrophils also displayed
sensitivity to mitochondrial complex inhibitors when undergoing
respiratory burst in response to the toll-like receptor (TLR)
agonist zymosan (Supplemental Fig. 4a), suggesting that mito-
chondrial function may also play a role in response to pathogens
in immature neutrophils. Together these data demonstrate that
neutrophils with enhanced mitochondrial capacity, can more
effectively maintain respiratory burst when glucose utilisation is
restricted.
4T1 tumours elicit mitochondrial metabolism in neutrophils.
Neutrophils are often expanded in tumour bearing mice and
cancer patients. Tumour elicited neutrophils have previously been
characterised as a type of MDSC, a heterogeneous population of
immature neutrophils and monocytes with functional differences
from healthy blood neutrophils. Therefore, we asked whether the
immature neutrophils expanded in tumour bearing mice might
also possess enhanced mitochondrial function.
4T1 mammary tumours produce the c-Kit ligand, SCF33, and
have been shown to elicit expansion of Ly6Ghi Ly6Clow c-Kit+
myeloid cells34. Indeed, neutrophils were signiﬁcantly expanded
in the bone marrow, spleen and blood (Supplemental Fig. 5a) of
mice bearing 4T1 tumours, with large numbers inﬁltrating the
TME (Supplemental Fig. 5b). Moreover, we found that both the
frequency of c-Kit+ neutrophils and the surface expression of c-
Kit on these cells was signiﬁcantly increased in the circulation of
tumour bearing mice (Fig. 4a and Supplemental Fig. 5c).
However, expression of Ly-6G, CD62L and CXCR2 were not
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Fig. 3 Mitochondrial capacity aids ROS production in low glycolysis. a Area under the curve (AUC) oxygen consumption rate (OCR) (total oxygen
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altered in 4T1 elicited neutrophils (Supplemental Fig. 5d) and
immature nuclear morphology did not associate with c-Kit
expression (Supplemental Fig. 5e). Assessment of mitochondrial
metabolism demonstrated that 4T1 elicited splenic neutrophils
possessed signiﬁcantly increased ATP synthase dependent and
maximal OCR (Fig. 4b) attributable to an increase in fatty acid
oxidation (Fig. 4c). Increased mitochondrial metabolism was also
observed in blood circulating neutrophils from 4T1 bearing mice,
suggesting that this metabolic programming was systemic
(Supplemental Fig. 5f). Assessment of tumour associated
neutrophil metabolism proved technically challenging, with
ex vivo measurement of ECAR or OCR proving unfruitful
(Supplemental Fig. 5g) and as such splenic neutrophils are
investigated as a 4T1 elicited population.
4T1 elicited neutrophils possessed a greater mitochondrial
membrane potential (Fig. 4d) and imaging of active mitochon-
dria in 4T1 elicited and naive splenic neutrophils supported this
(Fig. 4e). Assessment of fully-assembled respiratory chain
complexes by native immunoblot revealed that neutrophils from
tumour bearing mice had increased levels of complexes I
(NDUFS1) and IV (MTCO1), and signiﬁcantly increased
complex IV activity by in gel activity assay (Fig. 4f, Supplemental
Fig. 5h). Interestingly, unlike bone-marrow derived c-Kit+
neutrophils from naive mice, mitochondrial complexes II
(SDHB) (Fig. 4f) and III (UQCRFS1) (Supplemental Fig. 5i)
were not increased in 4T1 elicited neutrophils. Furthermore,
both naive and 4T1 elicited neutrophils displayed similar
complex II activity (Supplemental Fig. 5h). This suggests that
mitochondrial capacity in tumour elicited neutrophils, although
similarly enhanced, is distinct from immature neutrophils in
naive mice and perhaps this capacity is differentially utilised.
Analysis of metabolite content revealed that, similar to c-Kit+
bone marrow neutrophils, 4T1 elicited neutrophils had higher
levels of multiple amino acids as compared to naive neutrophils,
again suggesting higher levels of anaplerotic metabolism29.
Furthermore, IPA highlighted enrichment of the glutathione
synthesis pathway in 4T1 elicited neutrophils, which is indicative
of enhanced antioxidant capacity35 (Supplemental Fig. 5i) and
perhaps a response to increased ROS production associated with
enhanced mitochondrial function.
M
ito
ch
on
dr
ia
l m
as
s
(T
MR
E 
MF
I)
80
60
40
20
0
80
60
40
20
0
50
40
30
20
10
0
30,000
20,000
10,000
0
30
20
10
0
O
CR
 (p
mo
l/m
in)
O
CR
 (p
mo
l/m
in)
O
CR
 (p
mo
l/m
in)
%
 c
-K
it+
 
n
e
u
tro
ph
ils
n
M
Lu
m
in
es
ce
nc
e 
(A
U)
M
FI
 D
CF
DA
BM Spleen Blood 0 10050
Time (min)
1000
750
1 × 105
8 × 104
6 × 104
4 × 104
2 × 104
0
500
250
2DG 2DG R/A 2DG
n.s
**
*
2DG R/A 2DG 2DG R/A
0
60
40
20
0
NADPH ATP
ATP Max 4T1
n.s
4T1
4T1
4T1
Non FAO
FAO
Naive
Naive
Naive
Naive O
lig
o
FC
CP
R
/A
A
*
*
4T1Naive
*** *
*********
4T1
Naive
4T1
Naive
4T1
Naive
a b c d
e
i jh
400
300
200
100
0
400
300
200
100
0
100
75
50
25
0
R
el
at
iv
e 
AU
C
O
CR
 (p
mo
l/m
in)
4T14T1 Naive
0 100 200
Time (min)
300 0 100 200
Time (min)
300
Control
2DG
Naive
4T1NaiveMTCO1(CIV)SDHB (CII)NDUFS1(CI)
1,048
720
480
242
146
1,048
720
480
242
146
CIV
CII
CI
N
aï
ve
4T
1
N
aï
ve
4T
1
N
aï
ve
4T
1
N
aï
ve
4T
1
N
aï
ve
4T
1
N
aï
ve
4T
1
1,048
720
480
242
146
f g
***
Fig. 4 4T1 tumours elicit mitochondrial metabolism in neutrophils. a The percentage of neutrophils that are c-Kit+ in naive and 4T1-bearing Balb-c mouse
tissues (n= 5 per group). b Representative mitochondrial stress tests (left) of splenic neutrophils from naive and 4T1-bearing mice (oligomycin (Oligo),
Carbonylcyanide-4(triﬂuoromethoxy)phenylhydrazone (FCCP), rotenone (R) and antimycin A (AA). ATP synthase-dependent and maximal oxygen
consumption rate (OCR) quantiﬁed from multiple experiments (right, n= 4 per group). c ATP synthase OCR that is dependent on fatty acid oxidation (FAO)
was assessed using etomoxir. Data (n= 4 per group) from two independent experiments. d Median ﬂuorescent intensity (MFI) of tetramethylrhodamine
ethyl ester (TMRE) staining in splenic neutrophils from naive and tumour-bearing mice (n= 3). e Representative images of splenic neutrophils from tumour-
bearing and naive mice stained with mitotracker CMXROS (100 μM) and Hoechst 33342 (3.25 μM), scale bar represents 20 μm. f Native immunoblots for
mitochondrial complex I (CI, NDUFS1) Complex II (CII, SDHB) and Complex IV (CIV, MTCO1) of splenic neutrophils from naive and 4T1-bearing mice. g
Representative OCR of splenic neutrophils from tumour-bearing or naive mice following stimulation with phorbol 12-myristate 13-acetate (PMA) (arrow) in
the presence or absence of 2-deoxy glucose (2DG) (dotted line). Quantiﬁcation of area under the curve (AUC) of 2DG-stimulated neutrophils relative to
PMA alone from multiple experiments (naive n= 4, 4T1 n= 6). h MFI of 2′,7′-dichloroﬂuorescin diacetate (DCFDA) (5 μM) in splenic neutrophils from
tumour-bearing or naive mice in response to PMA (20min) following stimulation with the indicated compounds (n= 3). i, j NADPH and ATP levels in
splenic neutrophils from tumour-bearing or naive mice following stimulation with PMA in the presence the indicated compounds. Data (n= 6) are from two
independent experiments. Data were analysed by two-way ANOVA with Sidak’s (h–j) or Tukey’s (a–c) multiple comparisons indicated, or Student’s t-test (d,
g). All error bars show mean ± SEM. Concentrations were: Rotenone (100 nM), Antimycin A (1 µM), 2-DG (100mM), PMA (1 µg/ml), FCCP (660 nM),
Oligomycin (1.26 µM), VAS-2870 (10 μM) and etomoxir (100 µM). p Values *<0.05, **<0.01, ***<0.001. All error bars display mean ± SEM
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-07505-2
6 NATURE COMMUNICATIONS |          (2018) 9:5099 | DOI: 10.1038/s41467-018-07505-2 | www.nature.com/naturecommunications
4T1 elicited neutrophils were better able to maintain
respiratory burst when glucose metabolism was limited, when
compared to naive neutrophils (Fig. 4g). OCR measurements of
respiratory burst was supported by DCFDA staining (Fig. 4h).
Here, enhanced glucose-independent ROS of 4T1 elicited
neutrophils was sensitive to mitochondrial inhibition. Lastly,
similar to c-Kit+ cells from bone marrow, tumour-elicited
neutrophils maintained increased cellular NADPH levels through
mitochondrial function during inhibition of glucose utilisation
(Fig. 4i). ATP levels followed a similar pattern but were not
signiﬁcantly affected (Fig. 4i). Together these data suggest that
enhanced c-Kit expression in 4T1 bearing mice correlates with an
altered metabolic state in peripheral neutrophil populations
where mitochondrial metabolism is increased due to increases in
fatty acid utilisation required for maintenance of NADPH levels.
SCF-c-Kit signalling drives neutrophil metabolic adaptations.
Next, we investigated how 4T1 tumours support the altered
metabolic phenotype in neutrophils. The correlation between c-
Kit expression and mitochondrial metabolism in bone marrow
neutrophils (Fig. 1e, g, h) and 4T1 elicited neutrophils (Fig. 4a, b),
together with the production of Kit ligand (SCF)33 (supplemental
Fig. 6a) and absence of c-Kit expression in 4T1 tumour cells
(Supplemental Fig. 6b), suggested the c-Kit:SCF axis might be
involved in maintaining mitochondrial metabolism in neu-
trophils. To investigate this, a blocking antibody which antag-
onised c-Kit signalling was administered to mice following
establishment of the primary tumour. This treatment had no
effect on tumour growth (Fig. 5a) but signiﬁcantly reduced spleen
weights and peripheral neutrophil numbers (Fig. 5b, c). c-Kit
blockade signiﬁcantly reduced neutrophil basal and maximal
OCR (Fig. 5d). Accordingly, ATP synthase dependent OCR was
signiﬁcantly reduced together with fatty acid dependent mito-
chondrial function (Fig. 5e), whereas fatty acid independent
mitochondrial function remained unaffected. Furthermore,
blockade of c-Kit substantially reduced the ability of neutrophils
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from tumour-bearing mice to generate ROS in 2DG-simulated
limited glucose (Fig. 5f, g).
To rule out effects of c-Kit blockade on responses to
physiological SCF sources, and to rule out antibody mediated
depletion, we generated a SCF null 4T1 cell line (supplemental
Fig. 6c, d). SCF null tumours (51-1) were smaller when compared
to tumours competent in SCF production (50-1) (Fig. 5h).
Additionally, spleen weight, neutrophil numbers and c-Kit
expression were all reduced in mice bearing SCF silenced 4T1
tumours (Fig. 5i–k). Furthermore, splenic neutrophil ATP
synthase dependent OCR was reduced in mice bearing these
tumours and similar to c-Kit blockade, only the proportion
dependent on fatty acid oxidation was affected (Fig. 5l). Finally,
this reduction in mitochondrial metabolism left neutrophils from
hosts bearing SCF silenced tumour less able to maintain
respiratory burst in glucose limited conditions (Fig. 5m). These
data demonstrate that tumour elicited c-Kit signalling drives both
the increase in neutrophil number and mitochondrial ﬁtness
resulting in an oxidative population of neutrophils which use fatty
acid metabolism to maintain mitochondrial function.
Tumour elicited neutrophils suppress T cell in low glucose.
Neutrophils are capable of suppressing T cells via ROS
production14,36 and glucose utilisation by tumours can lower the
availability of glucose in situ22. We therefore hypothesized that
tumour elicited neutrophils might use their mitochondrial capa-
city to maintain suppressive activity in the glucose-depleted TME.
Injection of a luminol derivative (L-012) into the peritoneal cavity
of tumour bearing mice lead to detection of MPO activity and
ROS production at the tumour site whereas naive controls had no
signiﬁcant ROS production (Fig. 6a). Dissociation of the tumour
and subsequent DCFDA staining demonstrated that ly6G+ cell
fractions produced signiﬁcantly more ROS than the Ly6G− cell
fraction and that this ROS production was a characteristic of
tumour-associated neutrophils and not neutrophils isolated from
other tissues such as the spleen (Fig. 6b). Interestingly, neu-
trophils isolated from tumours which did not produce kitl (51–1)
and therefore did not display the altered metabolic phenotype
(Fig. 5l), were less likely to produce ROS directly ex vivo
(DCFDA+) (Fig. 6c). Previous reports have suggested that neu-
trophils need to be in close proximity to, or even in contact with,
T cells in order to deliver inhibitory ROS37. Indeed, neutrophils,
including c-Kit+ cells, were readily detected in close proximity
with CD3+ T cells in the TME (Fig. 6d) and furthermore tended
to be in close proximity to CD4+ T cells, particularly in the outer
regions of the tumour, whereas CD8+ T cells did not co-localise
with neutrophils (Fig. 6e, f)
Co-culture assays demonstrated that activated neutrophils
reduced T cell viability, proliferation and interferon-γ (IFN-γ)
production (Supplemental Fig. 7a,b,c). Tumour elicited neutro-
phils were no more suppressive when compared to naive controls
prior to stimulation. However, following stimulation, neutrophils
from 4T1 bearing mice induced signiﬁcantly greater T cell death
(Fig. 6g). Additionally, pre-treatment of neutrophil cultures with
2DG revealed that tumour-elicited neutrophils maintained a
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greater proportion of CD4+ T cell killing, following the inhibition
of glucose metabolism (Fig. 6h). Although activated neutrophils
reduced the viability of CD8+ T cells, this effect was not
maintained following 2DG treatment, suggesting that CD8+
T cells are less susceptible to low level neutrophil activity
(Supplemental Fig. 7d). Finally, we found that IFN-γ production
by T cells was signiﬁcantly reduced when cultured in the presence
of activated neutrophils from tumour bearing mice during 2DG
treatment (Fig. 6i). Together these data strongly suggest that 4T1
elicited oxidative-neutrophils can maintain their enhanced T cell
suppression even in conditions where glucose utilisation is
limited, whereas glycolytic-neutrophils from naive mice cannot.
Cancer patient neutrophils possess increased OXPHOS. To add
context to our animal model data, we assessed whether oxidative
metabolism might be present in neutrophils from cancer patients.
Analysis of peripheral blood neutrophils (CD14−, CD15+)
revealed that, compared to healthy donors, patients harbouring
ovarian cancers had an increased proportion of neutrophils with
intermediate expression of CD10 and CD16; characteristics pre-
viously reported as indicative of immature phenotype38,39
(Fig. 7a, b). Similar to our ﬁndings in mice, immature CD10int
neutrophils possessed greater mitochondrial content (Fig. 7c) and
concordantly, cancer patient neutrophils possessed greater ATP
synthase dependent OCR compared to healthy controls (Fig. 7d).
Together these data suggest, that similar to our observations in
4T1 bearing mice, in cancer patients, neutrophils with enhanced
mitochondrial mass and oxidative metabolic phenotype accu-
mulate in peripheral blood, potentially endowing them with the
fuel plasticity and the ability to suppress immunity within the
limiting glucose environment of tumours which we have identi-
ﬁed in mice (Fig. 8).
Discussion
Neutrophils are often discounted as a homogenous, short-lived
and one-dimensional population, with many studies ignoring
their importance in numerous physiological processes. This
dogma is now being challenged, particularly in cancer16,27. In this
study, we characterise the mitochondrial activity of neutrophils
and ﬁnd that when isolated from different tissue niches, neu-
trophils possess distinctly different metabolic phenotypes. In
agreement with previous studies23, we ﬁnd that mitochondrial
function is progressively lost as neutrophils mature, lose c-Kit
expression and are released to the circulation and distant tissues
such as the spleen. In contrast, the mitochondria rich phenotype
of cancer-associated neutrophils is maintained by c-Kit signalling,
as a result of tumour derived SCF33. Our ﬁnding that c-Kit sig-
nalling supports mitochondrial mass, function and fatty acid
oxidation is consistent with a previously reported role40. Mito-
chondria rich neutrophils are able to employ their respiratory
capacity to support the generation of ROS during the stress of
respiratory burst. These cells maintain the ability to produce ROS
in conditions where glucose utilisation, and therefore pentose
phosphate pathway (PPP) derived NADPH, is limited. The result
is tumour-promoted maintenance of neutrophil populations
capable of maintaining NOX-derived ROS and suppression of
T cells, even in nutrient limited conditions, such as the low
glucose environment of advanced tumours.
Recent studies from our laboratory and others have demon-
strated that macrophages also depend on mitochondrial support
for ROS generation during responses to pathogens30,31,41. These
data showed that macrophage mitochondria favour the use of
complex II, succinate dehydrogenase (SDH), whilst uncoupling
their ETC from OXPHOS to directly drive substantial ROS
generation by complex III. However, the data we present here
suggests that neutrophils utilize their mitochondria to support
ROS generation via a different mechanism, where OXPHOS does
not become uncoupled from the ETC, and complex V (ATP
synthase) activity is required to support glucose-independent
respiratory burst. However, despite effects on ATP production in
bone marrow-derived neutrophils, mitochondrial inhibition did
not similarly affect tumour-elicited splenic neutrophils. Further-
more, ATP levels were unaffected by disruption of fatty acid
metabolism, which is discordant with effects on respiratory burst.
Together these data suggest that maintenance of ATP levels does
not fully account for the mechanism by which neutrophils
maintain their respiratory burst in conditions where glucose
metabolism is inhibited.
Previous reports have demonstrated that mitochondria can act
as a direct source of ROS in human neutrophils32,42. In agree-
ment with this we ﬁnd that mice deﬁcient in the NOX subunit
p47 are able to produce minimal ROS in response to PMA using
DCFDA, however, we could not identify production of ROS with
APF (Supplemental Fig. 3f). This is likely due to the different ROS
species detected by these reagents. DCFDA detects H2O2 that can
be generated either by NOX2 or the ETC. However, APF also
detects other ROS and RNS species, such as hypochlorite, that are
generated downstream of NOX2 activation, by the enzyme
myeloperoxidase. Additionally, this PMA-induced ROS coincided
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with increased mitochondrial activity in p47−/− neutrophils,
suggesting this organelle is the source of the minimal ROS
detected. Therefore, our evidence clearly supports the indirect
involvement of the ETC in ROS generation.
We show that p47−/− neutrophils could not engage in sig-
niﬁcant ROS production and, in the absence of glucose metabo-
lism, NOX inhibition disrupted respiratory burst. Furthermore,
NADPH levels correlated with ROS production and were sig-
niﬁcantly affected by either ETC inhibition or disruption of fatty
acid metabolism. These data strongly suggest that oxidative
neutrophils are able to maintain NOX activity independently of
glucose by deriving NADPH via an alternative mitochondria-
dependent source. Neutrophil NADPH levels have been reported
to be highly dependent on glucose metabolism through the
enzyme glucose-6-phosphate dehydrogenase, the ﬁrst step of the
PPP which is vital for neutrophil respiratory burst43,44. There are
two possible candidates for mitochondria-dependent NADPH
production. Malic enzyme 1 (ME1) which converts malate to
pyruvate and isocitrate dehydrogenase (IDH1) converts iso-
citrate to α-ketoglutarate, both reducing NADP+ and yielding
NADPH45. Both of these enzymes are cytosolic, but are depen-
dent on TCA activity and subsequent export of citrate to the
cytoplasm through the citrate–malate exchanger. Interestingly,
macrophages have been reported to use this mechanism to
maintain NADPH during glucose deprivation46. Regardless of its
source, mitochondria-dependent NADPH allows oxidative neu-
trophils to support NOX activity from a variety of cellular fuels,
giving oxidative neutrophils a functional advantage particularly in
low glucose environments.
Despite their metabolic distinctiveness, neutrophils from 4T1-
bearing hosts did not show altered expression of other surface
markers and many remain c-Kit−. Furthermore, although
immature nuclear morphology was increased in 4T1 neutrophil
populations, it did not correlate with expression of c-Kit,
suggesting immature nuclear morphology is simply a hallmark of
increased neutrophil turnover rate to maintain high circulating
numbers, as seen in emergency granulopoiesis47. Finally, acti-
vated neutrophils from naive mice were also able to induce T cell
death, albeit to a lesser extent than tumour-elicited neutrophils,
suggesting that, in general, neutrophil activation is counter-
productive to T cell function. We therefore suggest that, as
opposed to generating an immunosuppressive population,
tumours such as 4T1 may simply induce immune dysregulation,
promoting neutrophil activation to inhibit adaptive anti-tumour
immune responses. Furthermore, given previous reports of c-Kit+
progenitors and neutrophils with increased lifespans in the per-
iphery during infection48, it is possible that c-Kit+ mitochondria
rich neutrophils can exist outside of the cancer setting and may
represent a physiological subset vital for host defence to
pathogens.
There are many different proposed mechanisms for neutrophil/
MDSC-mediated immune suppression, including arginase
expression49, sequestration of extracellular cysteine50 and IL-10
production51. However, ROS production has most often been
reported to be the major contributor to immunosuppression by
neutrophils in the tumour setting14,36. Additionally, MDSC have
been reported to be more suppressive when derived from the
tumour site52,53 and, until now, it has been difﬁcult to reconcile
the described role of neutrophil ROS in immunosuppression with
the reported dependency of these cells on glucose, a fuel widely
described as being limiting in the TME22. Our data demonstrate
that the likely explanation lies in the unexpected heterogeneity of
neutrophil metabolic programming. Clearly, different neutrophil
populations can have dramatically different metabolic states that
permit them to adapt to niches with different fuel availability.
Indeed, silencing of kitl in tumours reduced both neutrophil
oxidative metabolism and their activity at the tumour site. Thus,
it appears that cancers have apparently subjugated an otherwise
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Fig. 8 Tumours promote metabolically adapted suppressive neutrophils. Neutrophils produce ROS which is capable of disrupting CD4+ T cell viability and
function in the tumour microenvironment. Glycolytic neutrophils rely on glucose to maintain production of ROS and thusly in the glucose-deprived tumour-
microenvironment (TME) glycolytic neutrophil activity is predicted to be limited. However, 4T1 tumours elicit mitochondria rich oxidative-neutrophils
through aberrant stem cell factor (SCF)/c-Kit signalling. Oxidative neutrophils are able to maintain NADPH-oxidase dependent ROS production in the
absence of glucose utilisation through fatty acid dependent mitochondrial function to maintain NADPH levels. This c-Kit dependent mechanism allows
neutrophils to overcome nutrient limitations and suppress anti-tumour immunity in the glucose deprived TME
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normal process of physiology, through release of factors such as
SCF, to force the accumulation of mitochondria rich cells26 in the
glucose poor TME22, thereby circumventing this nutrient lim-
itation. Interestingly, human cancers also appear to promote
accumulation of mitochondria rich neutrophils, suggesting that
tumour elicited metabolic adaptions in neutrophils may also play
a role in human disease. Targeting of this function may prove an
attractive therapeutic approach for patients with high neutrophil
to lymphocyte ratio and poor prognosis. Furthermore, we suggest
that this heterogeneity in neutrophil metabolism is likely to play a
role in multiple inﬂammatory disease states which recruit
immature neutrophils, such as lupus54.
Methods
Reagents. All reagents were from Sigma unless otherwise stated. Rotenone, anti-
mycin A, 2-deoxyglucose (2-DG), oligomycin, glutamate (pH 7.4 with NaOH),
luminol, dodecyltrimethylammonium chloride (DTAC), atpenin (Cayman Che-
micals), etomoxir, PMA, mitotracker green, CMX-ROS, Hoechst 33342, DCFDA,
APF, TMRE (Thermo-Fisher).
Mice. C57BL/6J and NOX deﬁcient p47−/− mice were maintained and bred in the
Frederick National Laboratory Core Breeding Facility. NOX deﬁcient p47−/− mice
were a kind gift from Dr. Steven Holland (National Institute of Allergies and
Infectious Diseases, Bethesda, USA). Balb cJ mice were purchased from the Jackson
Laboratory. Mice were used in accordance with an approved protocol by the NCI
Frederick Institutional Animal Care and Use Committee (Permit Number:
000386). Experiments on C57BL/6J were carried out in male mice, Balb cJ
experiments were carried out in female mice.
Primary cell preparation and puriﬁcation. Standard neutrophil isolation was
carried out by magnetic puriﬁcation. Cells were blocked with 4 μg/ml α-FcγIII
(2.4G2, in house) in wash buffer (phosphate buffered saline (PBS) with 5 mM
ethylenediaminetetraacetic acid (EDTA), 0.5% BSA) for 5 min on ice, before
addition of 20 μg/ml α-Ly-6G-Biotin (1A8, Biolegend) for 30 min on ice. Cells were
then magnetically sorted with streptavidin micro-beads and LS columns as per
manufactures instructions (Miltenyi Biotec). Purities were typically >97% for bone
marrow neutrophils, in spleen purities ranged from 70 to 95%. For high purity
sorts required for metabolite proﬁle or protein isolation, neutrophils were further
puriﬁed by ﬂuorescent associated cell sorting by Ly6G+, purities obtained were
>95%. For c-Kit+/− neutrophil isolations, bone marrow neutrophils were extracted
as described above and then subsequently sorted by FACS for presence of c-Kit or
CXCR2 receptors, purities obtained were >95%. T cells were puriﬁed from spleens
and lymph nodes of naive mice and puriﬁed by Miltenyi Biotec pan T cell kit II
negative selection kit as per manufacturer’s instructions, purities obtained were
>97%. Human neutrophils were puriﬁed from peripheral blood using Miltenyi
Biotec Macsxpress Neutrophil isolation kit as per manufacturer’s instructions,
purities obtained were >90%. Human blood was obtained from healthy volunteers
who were recruited through the National Cancer Institute-Frederick research
donor program (approval number 16-003) and provided written informed consent.
All users of human materials were approved and appropriately trained. Whole
blood from cancer patients was collected on a study, conducted in accordance with
the Declaration of Helsinki, approved by the institutional review board at the
National Cancer Institute, and registered with Clinicaltrials.gov (NCT00034216).
All patients provided written, informed consent at study enrolment.
Extracellular ﬂux analysis. Neutrophil adherence was achieved by plating a
suspension of sorted neutrophils in seahorse assay media with 2 mM glutamine and
25 mM Glucose and spinning at the lowest acceleration to 45×g followed by natural
deceleration. Sorted neutrophils were seeded at 0.4 × 106 cells per well and incu-
bated for 1 h at 37 °C with no CO2. XF analysis was performed at 37 °C with no
CO2 using the XF-96e analyser (Seahorse Bioscience) as per manufacturer’s
instructions. Port additions and times were used as indicated in the ﬁgures.
Flow cytometry. Assessment of active mitochondrial mass was performed by
staining with TMRE (40 nM) or mitotracker green (5 nM) in complete sea horse
media (2 mM glutamine and 25 mM glucose) for 20 min at 37 °C. Excess mito-
chondrial dye was removed by washing and cells were further stained for surface
markers and acquired by ﬂow cytometry. ROS were measured by incubation with
either DCFDA (5 μM) or APF (5 μM) in complete sea horse media (2 mM gluta-
mine and 25 mM glucose) for 20 min at 37 °C. Neutrophils then received stimu-
lation with PMA (1 µg/ml) for a further 20 min, following which cells were washed
to remove excess dye and further stained for surface markers and acquired by ﬂow
cytometry. Cells were transferred to ﬂow cytometry tubes and analysed by a BD
LSRII or BD Fortessa ﬂow cytometer for ﬂuorescent analysis. Doublets and debris
were gates out before quantiﬁcation of median ﬂuorescent intensities with FlowJo
(FlowJo, LLC). See Supplementary Table 1 for information on antibodies used for
ﬂow cytometry.
Immunoblotting and in gel activity assays. Cellular fractionation into cytosol
and intact mitochondria was performed as follows55,56. Brieﬂy, cytosolic fractions
were isolated after permeabilisation with a buffer containing 0.1% digitonin in 210
mM mannitol, 20 mM sucrose and 4 mM HEPES. The supernatants after the ﬁrst
centrifugation step at 700×g for 5 min were subjected to 20,000×g for 15 min The
supernatants after the second centrifugation step were saved as cytosolic (soluble)
fractions. The crude preparation of mitochondria isolated by differential cen-
trifugation was lysed in lysis buffer I containing 50 mM BisTris, 50 mM NaCl, 10%
w/v Glycerol, 0.001% Ponceau S, 1% Lauryl maltoside, pH 7.2, protease and
phosphatase inhibitors.
The NativePAGE Novex Bis-Tris gel system (Thermo Fisher Scientiﬁc) was
used for the analysis of the mitochondrial respiratory chain complexes, with the
following modiﬁcations: only the Light Blue Cathode Buffer was used; 20 μg of
mitochondrial protein extracts were loaded/well; the electrophoresis was performed
at 150 V for 1 h and 250 V for 2 h. For the native immunoblots, PVDF was used as
the blotting membrane. The transfer was performed at 25 V for 4 h at 4 °C. After
transfer, the membrane was washed with 8% acetic acid for 20 min to ﬁx the
proteins, and then rinsed with water before air-drying. The dried membrane was
washed 5–6 times with methanol (to remove residual Coomassie Blue G-250),
rinsed with water and then blocked for 2 h at room temperature in 5% milk, before
incubating with the desired antibodies diluted in 2.5% milk overnight at 4 °C. In
order to avoid strip and reprobing of the same membrane, which might allow
detection of signals from the previous IBs, samples were loaded and run in
replicates on adjacent wells of the same gel, and probed independently with
different antibodies.
In-gel Complex I, Complex II and Complex IV activities were performed as
follows56–58. For Complex I activity, after resolution of the respiratory chain
complexes by BN-PAGE, the gel was incubated with 0.1 M TrisCl, pH 7.4,
containing 1 mg/ml nitrobluetetrazolium chloride (NBT) and 0.14 mM NADH at
room temperature for 30–60 min For complex II, detection of succinate CoQ-
reductase activity (SQR) (CoQ-mediated NBT reduction) was performed by
incubating the gel for 30 min with 84 mM succinate, 2 mg/ml NBT, 4.5 mM EDTA,
10 mM KCN, 1 mM sodium azide and 10 μM ubiquinone in 50 mM PBS, pH 7.4.
For complex IV, the gel was incubated in 50 mM phosphate buffer pH 7.4
containing 1 mg/ml DAB (3,3′-diaminobenzidine) and 1 mg/ml cytochrome c at
room temperature for 30–45 min
Luminescence assays. Magnetically sorted neutrophils were seeded at 0.25–0.3 ×
106 cells per well of a 96-well luminescence plate in complete seahorse media
(glucose 25 mM and L-glutamine 2 mM) and incubated for 30 min at 37 °C. For
H2O2 measurements 400 µM luminol was added to the media and cells were sti-
mulated for 20 min with 2DG (100 mM), Rotenone (100 nM) and antimycin A (1
µM) or etomoxir (100 µM) following which cells were stimulated with PMA (1 µg/
ml) and immediately measured for luminescence in a 96-well luminescence plate
reader and luminescence readings were measured every 6 min for 6 h. For ATP and
NADPH measurements, cells were lysed in passive lysis buffer (Promega) or 0.1 M
NaOH with 0.5% DTAC for ATP or NADPH determination respectively. Relative
ATP was determined using the ATP assay kit (Abcam/Thermo-Fisher) and
NADPH was determined using the NADPH-Glo assay kit (Promega) as per
manufacturer’s instructions.
4T1 tumour model. The 4T1 cell line was maintained from frozen stocks at low
passage number and cultured using complete DMEM media (10% foetal calf
serum, 2 mM glutamine and penicillin/streptomycin 100 U/ml/100 μg/ml). Female
Balb/cJ mice received a single sub cutaneous injection of 1 × 105 4T1 cells or sterile
PBS into the 3rd mammary pad. Tumour size was determined using calipers. The
maximum tumour size permitted by the NCI-Frederick IACUC, and adhered to in
this study, was 20 mm at the largest diameter. Mice were monitored daily and
euthanised if they displayed any signs of toxicity (rough hair coat, laboured
breathing, lethargy, rapid weight loss, difﬁculty in obtaining food or water) or if
tumours ulcerated, became necrotic or infected. Mice were euthanized 14 days post
injection and tissues such as spleen and tumour were removed for experimentation.
C-Kit blocking experiments were performed by intraperitoneal injections of anti-c-
Kit or appropriate isotype control (50 μg) on daily for commencing from day 10.
CRISPR-cas9 silencing. CRISPR guide RNAs (sgRNA) were designed to target the
SCF gene kitl located on chromosome 10 of the mouse genome using the sgRNA
scorer 2.0 and candidates were selected based on their high predicted activity and
lack of off-target effects. Selected sgRNA were cloned into pX458 cloning vector
containing a Cas9-2A-GFP by ligating two annealed oligos following digestion with
Bbsl restriction enzyme. 4T1 cell lines were transfected by CRISPR plasmid using
x-tremeGENE (Sigma-Aldrich) transfection reagent at a ratio of 3:1 (90 μl X-
tremeGENE : 30 μg of plasmid) in 1000 μl of serum free Optimem and incubated
for 15 min at room temperature. Transfection suspension was added to 10 ml of
RPMI and added directly to cells. Following transfection, GFP+ 4T1 cells were
found to be typically 4% of total cells and were puriﬁed by ﬂuorescent associated
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cell sorting and placed in single cell cultures. Cultures were ﬁrst screened for SCF
production using ELISA (Sigma-Aldrich), selected candidates had editing efﬁ-
ciencies conﬁrmed by Illumina Miseq sequencing for non-homogenous end joining
(NHEJ) induced mutation rates. CRISPR silenced 4T1 cell lines were compared to
4T1 transfected cell lines which failed to silence kitl gene.
L-012 luminescence. 2D chemiluminescence imaging was performed on tumour
bearing mice using the IVIS SPECTRUM scanner (PerkinElmer Inc., Waltham,
MA) in the supine position. 250 µl of L-012 (Wako Chemicals) in PBS was
administered to each mouse IP (60 mg/kg). Mice body temperature was maintained
at 37 °C during the procedure with a heated pad located under the anaesthesia
induction chamber, imaging table, and post procedure recovery cage. Anaesthesia
was initially set at 3% isoﬂurane with ﬁltered (0.2 µm) air at 1 l/min ﬂow rate for
3–4 min and then modiﬁed for imaging to 2% with O2 as a carrier with a ﬂow rate
1 l/min. Dynamic 2D images were acquired at every 2 min for the total of 50 min
with the following parameters: excitation ﬁlter-blocked, emission ﬁlter-open, f/stop
1, medium binning (8×8) and 2-min exposure. Acquisition and analysis was per-
formed via vendor speciﬁc software Living Image (version 4.3.1) (PerkinElmer Inc,
Waltham, MA).
Confocal microscopy. For neutrophil mitochondrial images, isolated neutrophils
were incubated in complete sea horse media (2 mM glutamine and 25 mM glucose)
for 20 min at 37 °C with mitotracker CMX ROS (100 nM). Cells were washed in
PBS and incubated with Hoechst (2 μg/ml) for 20 min with 5 °C after which cells
were washed in PBS. Neutrophils were placed in a cytospin cartridge and spun at
800 rpm and spun for 3 min. Cells were then ﬁxed in 4% PFA for 20 min, washed
and a coverslip was added. A Zeiss UV-510 confocal microscope and 63× oil
immersion objective lens was used to capture images using differential interference
contrast, 405 and 561 laser paths (pinhole size= 1 airy unit).
Tumour sections were processed fresh-frozen sections and were washed with
PBS, mild-ﬁxed with acetone at 4 C, permeablised with 0.05% Triton in PBS and
blocked with 5% BSA in PBS. Sections incubated at room temperature for 1 h with
the following antibodies (1:100, all from Biolegend): FITC anti-mouse CD3, PerCP/
Cy5.5 anti-mouse GR-1, APC anti-mouse c-Kit and counterstained with DAPI.
Images were analysed using Fiji (ImageJ).
Immunohistochemistry analysis of 4T1 tumours. Tumours were excised, washed
and cut in half. One half was ﬁxed by submersion in 10% neutral buffered formalin
for 24 h and parafﬁn-embedded. The other half was submerged in OCT compound,
mounted and snap frozen in a dry ice/methanol slurry. For immunohistochemistry
analysis, 10 µm parafﬁn sections were deparafﬁnized, blocked and stained with
either a biotinylated rat anti-mouse CD4 monoclonal antibody (1:250, eBioscience)
or CD8a monoclonal antibody (1:250, eBioscience). EDTA or Citrate was used as
antigen retrieval agent. Images were taken using an Olympus BX40 microscope.
Primary metabolite analysis. Fluorescent associated cell sorted peritoneal neu-
trophils (5.0–10 × 106) were pelleted and snap-frozen in liquid nitrogen. Samples
were further processed and analysed at the West Coast Metabolomics Center
(University of California, Davis). Brieﬂy, samples were re-suspended with 1 ml of
extraction buffer (37.5% degassed acetonitrile, 37.5% isopropanol and 20% water)
at −20 °C, centrifuged and decanted to complete dryness. Membrane lipids and
triglycerides were removed with a wash in 50% acetonitrile in water. The extract
was aliquoted into two equal portions and the supernatant dried again. Internal
standards C08-C30 fatty acid methyl esters were added and the sample derivatized
by methoxyamine hydrochloride in pyridine and subsequently by N-methyl-N-
trimethylsilyltriﬂuoroacetamide for trimethylsilylation of acidic protons. GC-TOF
analysis was performed by the Agilent GC6890/LECO Pegasus III mass spectro-
meter. Samples were additionally normalized using the sum of peak heights for all
identiﬁed metabolites.
T cell suppression assay. Puriﬁed neutrophils were plated in 96-well U-bottomed
plates at 0.125 × 106 cells per well in RPMI supplemented with (Pen/Strep, 10%
FCS, 2 mM L-glutamine, 1 M HEPES, 0.1 mM nonessential amino acids) and
adhered by spinning at the lowest acceleration to 45×g followed by natural
deceleration. Neutrophils were incubated for 30 min–1 h at 37 °C followed by a 20
min stimulation with 2DG (100 mM) or vehicle control, after which cells were
stimulated with PMA (1 µg/ml) for 5 min. Neutrophil media was removed and cells
washed with fresh RPMI. Puriﬁed T cells were overlayed at 0.25 × 106 and co-
cultured for either 18 h for viability and IFNγ measurements (Fig. 6) or 72 h for
proliferation index (supplemental Fig. 7). T cell viability was assessed by Sytox
Green (ThermoFisher) uptake and subsequent ﬂow cytometry. BD cytometric bead
array kit was used to quantify Interferon-γ in supernatant taken 16 h after T cell
suppression assay, and was used as per manufacturer’s instructions. Proliferation
index was calculated by pre-culturing T cells with CellTrace Violet Cell Pro-
liferation Kit (ThermoFisher) by gating cells by their number of division and
assigning a generation number, where no division is 0 and 1 division is 1 and so on.
The following equation was used to calculate the proliferation index (PI), the
average number of divisions a dividing cell will go through, where i is the
generation number and n is the number of events in that generation number59,60.
PI ¼
Pi
1 i x
Ni
2iPi
1
Ni
2i
ð1Þ
Statistical analysis. Statistical analysis was performed by GraphPad Prism 6, with
the tests used indicated in the ﬁgure legend. Data log transformed where appro-
priate before analysis. *p < 0.05, **p < 0.01, ***p < 0.001. All error bars represent the
mean ± the standard error of the mean (SEM).
Data availability
All data is freely available from authors upon request.
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